WA Marston, J Hanft, P Norwood, R Pollak - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A randomized, controlled, multicenter study was undertaken
at 35 centers throughout the US and enrolled 314 patients to evaluate complete wound closure
by 12 weeks. Patients were randomized to either the Dermagraft treatment group or ... Cited by 50 - Related articles - All 2 versions
WA Marston, J Hanft, P Norwood, R Pollak - Diabetes Care, 2003 - ncbi.nlm.nih.gov OBJECTIVE: To determine if a human fibroblast-derived dermal substitute could promote the
healing of diabetic foot ulcers. RESEARCH DESIGN AND METHODS: A randomized,
controlled, multicenter study was undertaken at 35 centers throughout the US and ... Cited by 95 - Related articles - BL Direct - All 3 versions
[CITATION] Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective …
C Caravaggi, R De Giglio, C Pritelli, M Sommaria, S … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Complete ulcer healing was achieved in 65.3% of the treatment group and 49.6%
of the control group (P = 0.191). The Kaplan-Meier mean time to closure was 57 and 77
days, respectively, for the treatment versus control groups. Plantar foot ulcer healing was ... Cited by 45 - Related articles - BL Direct - All 5 versions
- ►alyamedikal.com.tr [PDF] JA Niezgoda, CC Van Gils, RG Frykberg, JP … - Advances in Skin & …, 2005 - journals.lww.com Jeffrey A. Niezgoda, MD, FACHM, FAPWCA, FACEP, is Medical Director, Center for Comprehensive
Wound Care and Hyperbaric Oxygen Therapy, St. Luke's Medical Center, Milwaukee, WI; Carl
C. Van Gils, DPM, MS, CWS, is Medical Director, Dixie Regional Medical Center Wound ... Cited by 39 - Related articles - All 6 versions
D Eisenbud, NF Huang, S Luke, M Silberklang - Wounds, 2004 - members.medscape.com Bioengineered skin substitutes have emerged over the past 20 years as the most carefully studied
and proven of the advanced wound management technologies. While the initial impetus for their
development was to replace autograft, allograft, and xenograft in burn applications, they ... Cited by 31 - Related articles - BL Direct - All 4 versions
JR Hanft, MS Surprenant - The journal of Foot and Ankle Surgery, 2002 - Elsevier A prospective, multicenter, randomized, controlled 12-week study was undertaken to evaluate
the effectiveness of a human fibroblast-derived dermis for treating foot ulcers in the diabetic
patient. This report summarizes the findings from one center. Following a 2-week ... Cited by 42 - Related articles - BL Direct - All 7 versions
AA Omar, AID Mavor, AM Jones, S Homer- … - European Journal of …, 2004 - Elsevier Background. A number of different treatment approaches have been recommended for the treatment
of venous ulceration, including local ulcer treatment, compression and drug therapy. Recent
advances in tissue engineering have resulted in living tissues being developed for ... Cited by 44 - Related articles - All 15 versions
[CITATION] AutoloGel™ Diabetic Foot Ulcer Study Group. A prospective, randomized, …
M Lı́mová - Dermatologic clinics, 2002 - Elsevier Chronic wounds have become a major medical problem in our society as well as the Western
world, which is due at least in part to the increasing average age of the population [1 and 2].
It is estimated that in the US alone there are more than 1.5 million patients with decubitus ... Cited by 15 - Related articles - BL Direct - All 3 versions
